[ad_1] A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Roche on Thursday said its […]
Continue readingTag: Eli Lilly and Co
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
[ad_1] Rebekah Carl poses with her prescription of Wegovy in New Columbia, Pennsylvania, U.S., November 13, 2023. Hannah Beier | Reuters Think a friend or […]
Continue reading
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
[ad_1] Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Patients taking […]
Continue reading
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11, 2023. Brendan McDermid | Reuters Think […]
Continue reading
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
[ad_1] The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images […]
Continue reading
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
[ad_1] Pavlo Gonchar | Lightrocket | Getty Images Amgen‘s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its […]
Continue reading
Amgen scraps experimental weight loss pill, moves forward with injection
[ad_1] The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Thursday […]
Continue reading
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
[ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little […]
Continue reading
Jim Cramer says GE Healthcare's unwarranted post-earnings plunge is a buying opportunity
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour […]
Continue reading
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli […]
Continue reading